Abstract.
Noninvasive positive pressure ventilation (NPPV) has reemerged as an effective strategy for reducing morbidity and mortality associated with acute exacerbations of chronic obstructive pulmonary disease (COPD). During acute respiratory failure, dynamic hyperinflation, intrinsic PEEP, and increased airway resistance result in a mechanical workload that exceeds inspiratory muscle capacity. NPPV provides augmentation of alveolar ventilation and respiratory muscle rest. Observational, cohort, and, more recently, randomized controlled trials have demonstrated the ability of NPPV to decrease the need for endotracheal intubation and decrease complications and mortality. NPPV performs better in COPD patients without significant comorbid illness. It should be initiated during COPD exacerbations if arterial pH is less than 7.35 or if the patient is severely distressed. Pressure support ventilation (10–20 cmH2O) via face mask is likely the optimal technique and, when successful, results in rapid clinical improvement.
Article PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Accepted for publication: 17 October 1996
Rights and permissions
About this article
Cite this article
Clark, H., Wilcox, P. Noninvasive Positive Pressure Ventilation in Acute Respiratory Failure of Chronic Obstructive Pulmonary Disease . Lung 175, 143–154 (1997). https://doi.org/10.1007/PL00007562
Published:
Issue Date:
DOI: https://doi.org/10.1007/PL00007562